Cargando…
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
Survivin is a member of the inhibitor-of-apoptosis proteins family. It is overexpressed in many different cancer types but not in the differentiated normal tissue. In addition, overexpression of survivin promotes cancer cell survival and induces chemotherapeutic drug resistance, making it an attract...
Autores principales: | Lin, Kun-Yuan, Cheng, Siao Muk, Tsai, Shing-Ling, Tsai, Ju-Ya, Lin, Chun-Hui, Cheung, Chun Hei Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862386/ https://www.ncbi.nlm.nih.gov/pubmed/27217778 http://dx.doi.org/10.2147/OTT.S101209 |
Ejemplares similares
-
Survivin – biology and potential as a therapeutic target in oncology
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2013) -
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2020) -
Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells
por: Lee, Jane Ying-Chieh, et al.
Publicado: (2016) -
Antisense of survivin inhibits cervical cancer growth in mice
por: Xu, Hui, et al.
Publicado: (2019) -
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
por: Lin, Tzu-Yu, et al.
Publicado: (2019)